Sep 19, 2017 12:00 pm UTC| Business
Data to highlight recent preclinical studies of SB 11285, a novel next-generation STING agonist HOPKINTON, Mass., Sept. 19, 2017 -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical...
ShopAdvisor to Showcase its Mobile Proximity Solutions at Path To Purchase Expo 2017
Sep 19, 2017 12:00 pm UTC| Business
Concord, MA, Sept. 19, 2017 -- ShopAdvisor, Inc., a leading provider of drive-to-store mobile proximity marketing solutions, announced today that it will be participating in the Path to Purchase Expo. At P2PX, the...
Ukiah Valley Sanitation District Board of Directors Announces New General Manager
Sep 19, 2017 12:00 pm UTC| Business
UKIAH, Calif., Sept. 19, 2017 -- Ukiah Valley Sanitation District (District) today announced that it has retained Joe Tait as its new General Manager. In his new role, Mr. Tait will be responsible for navigating the...
Altimmune to Provide Corporate Update at the Ladenburg Thalmann 3rd Annual Healthcare Conference
Sep 19, 2017 12:00 pm UTC| Business
GAITHERSBURG, Md., Sept. 19, 2017 -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, President and Chief Executive Officer of Altimmune, will present a...
Sep 19, 2017 12:00 pm UTC| Business
Chadds Ford, PA, Sept. 19, 2017 -- Legal support services consulting firm Mattern Associates, LLC announces the successful completion of an outsourcing RFP for Am Law 200 firm, Thompson Coburn LLP, improving the...
BOXX Introduces Workstation Featuring AMD Ryzen™ Threadripper™ Processor
Sep 19, 2017 12:00 pm UTC| Business
Austin, TX, Sept. 19, 2017 -- BOXX Technologies, the leading innovator of high-performance computer workstations, rendering systems, and servers, today introduced APEXX 4 6301, the first BOXX workstation to feature the...
Selecta Biosciences to Participate in Upcoming Investor Conferences
Sep 19, 2017 12:00 pm UTC| Business
WATERTOWN, Mass., Sept. 19, 2017 -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding unwanted immune...